文献速递系统性红斑狼疮

患者与家长对幼年型系统性红斑狼疮达标治疗试验的定性观点

'It is good to have a target in mind': qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究通过主题引导的半结构化访谈,探讨幼年型系统性红斑狼疮(JSLE)患者与家长对治疗目标、结局指标及未来达标治疗(T2T)研究设计的看法。患者与家长对可耐受症状的理解不同:患者倾向以既往经历、不可见或对生活影响小的症状为低疾病活动,家长更能接受可见体征但担忧器官受累与症状严重程度;总体上家庭偏好完全无症状且无治疗副作用,并关注疲劳与减少糖皮质激素。家庭认可T2T概念,但担忧就诊频率增加影响学业、家长就业与经济,并提出改良试验设计的建议。

要点

  • 患者与家长对低疾病活动的可耐受症状理解不同,需在目标设定中区分。
  • 家庭总体偏好儿童完全无症状且无持续治疗副作用,疲劳需用患者报告结局工具监测。
  • 家庭认可T2T有助于疾病控制与沟通,但担忧就诊频率增加影响学业与家庭经济。

核心结论

  • 患者与家长提供的观点可指导JSLE的T2T治疗目标与未来研究设计,仍需补充定量研究评估不同目标的可实现性与影响,以支持国际共识制定。

研究设计与样本

  • 对JSLE患者与家长进行主题引导的半结构化访谈,并对录音访谈采用主题分析方法进行分析。

主要发现

  • 患者与家长对可耐受症状的看法存在差异,患者常将既往经历、不可见或对生活影响小的症状视为低疾病活动。
  • 家长更能接受可见体征,但担忧潜在器官受累与症状严重程度。
  • 家庭总体偏好儿童完全无症状且无持续治疗副作用,并将疲劳视为特别具有挑战性。
  • 多数家庭认为减少糖皮质激素也是良好治疗目标。
  • 家庭认可T2T概念,但担忧就诊频率增加影响学业、家长就业与财务。

临床怎么用

  • 在JSLE达标治疗目标设定与试验设计中纳入患者和家长观点,重视疲劳监测与减少糖皮质激素的目标。
  • 设计T2T试验时需考虑减少就诊频率对学业、家长就业与经济的负面影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to explore patient and parental views on treatment targets, outcome measures and study designs being considered for a future JSLE treat-to-target (T2T) study. METHODS: We conducted topic-guided, semistructured interviews with JSLE patients and parents and analysed the audio recorded interviews using thematic approaches. RESULTS: Patients and parents differed regarding symptoms they felt would be tolerable, representing 'low disease activity'. Patients often classed symptoms that they had previously experienced, were 'invisible' or had minimal disruption on their life as signs of low disease activity. Parents were more accepting of visible signs but were concerned about potential organ involvement and symptom severity. Overall, patients and parents preferred that children were entirely asymptomatic, with no ongoing treatment side effects. They regarded fatigue as particularly challenging, requiring proper monitoring using a fatigue patient-reported outcome measure. Most families felt that reducing corticosteroids would also be a good treatment target. Overall, families liked the concept of T2T, commenting that it could help to improve disease control, help structure treatment and improve communication with clinicians and treatment compliance. They were concerned that T2T might increase the frequency of hospital visits, thus impacting upon schooling, parental employment and finances. Families made suggestions on how to modify the future trial design to mitigate such effects. CONCLUSION: This study provides guidance from patients and parents on T2T targets and study designs. Complementary quantitative studies assessing the achievability and impact of different targets (e.g. lupus low disease activity state or remission) are now warranted to inform an international consensus process to develop treatment targets.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Smith EMD, Gorst SL, Al-Abadi E, et al. 'It is good to have a target in mind': qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus. Rheumatology (Oxford). 2021. PMID: 33629109. doi:10.1093/rheumatology/keab173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。